Relay Therapeutics Inc (NASDAQ:RLAY) currently has a daily average trading volume of 2.63M but it saw 1477593 shares traded in last market. With a market cap of 505.76M USD, the company’s current market price of $2.95 came rising about 3.51 while comparing to the previous closing price of $2.85. In past 52 weeks, the stock remained buoying in the range of price level as high as $10.72 and as low as $1.77.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which initiated the stock as “Equal Weight” in its note to investors issued on April 17, 2025, recommending a price target of $4 for it. Jefferies upgraded its recommendation for the stock as a “Buy” from “Hold” on September 10, 2024 while assigning a price target range of $10.60-$16. Goldman issued its recommendations for the stock as it resumed the price target for the stock is $20.
Over the week, RLAY’s stock price is moving -3.28% down while it is -9.51% when we observe its performance for the past one month. Year-to-date it is -28.40% down and over the past year, the stock is showing a downside performance of -57.74%.
Currently, Relay Therapeutics Inc’s total number of outstanding shares is 170.48M with 1.51% of that held by the insiders while 106.26% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -43.73% and return on equity (ROE) at -45.46%. Stock’s beta reads 1.57. Stock has a price to book (P/B) ratio of 0.70 while price to sale or P/S ratio amounts to 65.85. Its return on asset (ROA) is -40.64% on average.
